About Qadvis
Qadvis is a Healthcare company based in Lund (Sweden) founded in 2013, and was acquired by Labquality in August 2024. Provider of clinical evaluation and risk management services for medical devices manufacturers. Qadvis offers products and services including Risk Management and Biocompatibility Assessment. Its focus areas include Medical Device Outsourcing. Its legal entity is QAdvis AB.
Company details
Qadvis was established in 2013 in Lund, Sweden, as a provider of clinical evaluation and risk management services within the medical devices sector. These services are delivered to manufacturers to support regulatory compliance, safety assessments, and clinical data analysis. Operations are centered in Europe, with a focus on assisting clients in meeting international standards for device approval and post-market surveillance.
- Headquarters Lund, Sweden
- Stage Acquired
- SectorsHealthcare
- Website qadvis.com
- Social LinkedIn
- Acquired by Labquality (Aug 2024)
- Legal Name Qadvis Ab
- Latest Funding Round$247.2K (USD), Grant
Jan 2019
- InvestorsEuropean Union
& 1 more
- Acquired byLabquality
(Aug 2024)
Products & Services of Qadvis
Qadvis offers a comprehensive portfolio of products and services, including Risk Management and Biocompatibility Assessment.
Risk management services for medical devices are provided by QAdvis to address challenges in the device life cycle.
Biocompatibility assessment services are offered by QAdvis to evaluate the safety and compatibility of medical devices.
Funding Insights of Qadvis
- Total Rounds 1
- Last Round Grant — $247,197
- First Round $247,197
(Jan 2019)
- Investors Count 1
All 1 funding rounds of Qadvis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | $247,197 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Qadvis
Qadvis has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Labquality.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Quality services are provided for healthcare, pharmaceutical, and medical industries. | 1971 | labquality.com | Helsinki, Finland |
Investor details for Qadvis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Qadvis
3 dated milestones of Qadvis across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Qadvis is founded.
- Funding First funding round of $247K.
- Exit Acquired by Labquality.
Web traffic of Qadvis
The website of Qadvis (qadvis.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 255.5% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Qadvis
Qadvis was founded in 2013 and raised its 1st funding round 6 years after it was founded.
Qadvis is headquartered in Lund, Sweden.
Qadvis was established in 2013 in Lund, Sweden, as a provider of clinical evaluation and risk management services within the medical devices sector. These services are delivered to manufacturers to support regulatory compliance, safety assessments, and clinical data analysis. Operations are centered in Europe, with a focus on assisting clients in meeting international standards for device approval and post-market surveillance.
Qadvis offers Risk Management and Biocompatibility Assessment.
Qadvis has 2 investors. Key investors include European Union, and Labquality.
Qadvis operates through Qadvis Ab.
Yes. Qadvis was acquired by Labquality in August 2024.